No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Express News | Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Here's Why Chimerix, Inc. (CMRX) Is Skyrocketing
Chimerix to Speak Today at The White House Cancer Moonshot Forum
JonesTrading Maintains Chimerix(CMRX.US) With Buy Rating, Maintains Target Price $7
Chimerix Announces NDA Submission For Dordaviprone - Quick Facts